Article

Has the USPSTF gone far enough with its new PCa grade?

Urology Times asked members of our editorial advisory board: Has the USPSTF gone far enough with its new draft recommendation on screening for prostate cancer?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

Related Videos
Martin Sanda, MD, considers potential future advancements in urology
Martin Sanda, MD, considers potential future advancements in urology
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Dr. Daniel Carson on telehealth vs in-person urology visits
Laura Bukavina, MD, on the need to integrate mental health support in GU cancer care
Laura Bukavina, MD, on the need to integrate mental health support in GU cancer care
Study: GU cancer survivors report difficulty affording mental health, dental care
Study: GU cancer survivors report difficulty affording mental health, dental care
Dr. Cary details the history of IU’s testicular cancer program
Dr. Cary details the history of IU’s testicular cancer program
Dr. Neal E. Rowe in an interview with Urology Times
Dr. Rowe highlights AUA course on the management of adrenal tumors
Dr. Rowe on potential future work with incidental adrenal tumors
Dr. Rowe on potential future work with incidental adrenal tumors
Dr. Jang on current state of immunotherapy in advanced GU cancers
Dr. Jang on current state of immunotherapy in advanced GU cancers
Developments in the penile cancer treatment paradigm
Developments in the penile cancer treatment paradigm
Why clinicians should join the Global Society of Rare Genitourinary Tumors
Why clinicians should join the Global Society of Rare Genitourinary Tumors
Related Content
Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer
May 14th 2025

Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer

Hannah Clarke
ACOU085 will be administered in 1 ear, with a matching placebo injection in the respective contralateral middle ear.
Destigmatizing Urology: Dr. Pettaway discusses penile cancer
March 29th 2022

Destigmatizing Urology: Dr. Pettaway discusses penile cancer

Urology Times staff
“When you compound the patient delay and…the physician delay, then you really get a delay in diagnosis,” says Curtis A. Pettaway, MD.
Urologist speaking with a male patient following a diagnosis of cancer. | Credit: Adobe Stock
February 4th 2025

Urologic Cancer Facts and Updates for World Cancer Day 2025

Patrick Campbell
A list of facts and trends to know about the current landscape of urologic cancer management and research in the US.
Dr. Richard Matulewicz discusses smoking cessation counseling and treatment among urologists
March 31st 2021

Dr. Richard Matulewicz discusses smoking cessation counseling and treatment among urologists

Urology Times staff
“Because so many disease processes that we deal with are related to tobacco use and smoking specifically… I think this is absolutely our domain,” says Richard S. Matulewicz, MD, of tobacco cessation counseling and treatment.
FDA approves subcutaneous nivolumab for solid tumors, including RCC
December 27th 2024

FDA approves subcutaneous nivolumab for solid tumors, including RCC

Hannah Clarke
The approval is supported by data from the phase 3 CheckMate-67T trial.
Behavioral intervention may improve psychological distress after testicular cancer
November 25th 2024

Behavioral intervention may improve psychological distress after testicular cancer

Hannah Clarke
The study showed significant reductions in both anxiety and depressive symptoms following the intervention.
© 2025 MJH Life Sciences

All rights reserved.